| Serial Number | 98895371 |
| Word Mark | ALLOSTERIS |
| Filing Date | Tuesday, December 10, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, June 24, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 14, 2026 |
| Goods and Services | Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, biotechnology, biomedicine, veterinary science and industrial biotechnology; natural science services, namely, scientific and medical research; clinical research in the fields of cardiovascular diseases, allergies, autoimmune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, and infectious diseases; clinical research in the fields of medical and biotechnological procedures, namely, radiology, chemotherapy and in vivo imaging; medical research laboratories; conducting evaluations in the field of new pharmaceuticals; consultancy relating to pharmaceutical research and development; drug discovery services; pharmaceutical drug development services, namely, drug design; research and development in the field of biotechnology; providing a web hosting platform for biotechnological research |
| Goods and Services | Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Pharmaceutical preparations and substances, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, autoimmune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 11, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 11, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | VIB VZW |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Gent 9052 BE |
| Party Name | VIB VZW |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Gent 9052 BE |
| Event Date | Event Description |
| Tuesday, December 10, 2024 | NEW APPLICATION ENTERED |
| Sunday, April 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 29, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, June 3, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 3, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 3, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 15, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 15, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 15, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 18, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 18, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, August 18, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 18, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 18, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 10, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 16, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 16, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 11, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, April 27, 2026 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 27, 2026 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Monday, June 22, 2026 | ASSIGNED TO PETITION STAFF |
| Tuesday, June 23, 2026 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Tuesday, June 23, 2026 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, June 23, 2026 | CASE RETURNED TO EXAMINATION |